Zhang et al. constructed a risk model for Estrogen receptor-positive (ER+) BC consisting of 4 CRGs, including DLD, DBT, DLAT, and ATP7A, that predicted immune infiltration, immune function, ICs, characteristic gene changes, and pathway activation in different scoring risk subgroups 65. The gene discussed is ATP7A; the disease is breast cancer.